Optimized 5-HT2b inhibitors for neuropsychiatric syndromes with cognitive dysfunction.

Saved in:
Bibliographic Details
Title: Optimized 5-HT2b inhibitors for neuropsychiatric syndromes with cognitive dysfunction.
Authors: Roy SM; Department of Pharmacology, Feinberg School of Medicine Northwestern University Chicago Illinois USA., Acquarone E; Taub Institute for Research on Alzheimer's Disease and the Aging Brain New York New York USA., Argyrousi EK; Taub Institute for Research on Alzheimer's Disease and the Aging Brain New York New York USA., Zhang H; Taub Institute for Research on Alzheimer's Disease and the Aging Brain New York New York USA., Staniszewski A; Taub Institute for Research on Alzheimer's Disease and the Aging Brain New York New York USA., Inoue A; Graduate School of Pharmaceutical Sciences Tohoku University Sendai Japan.; Graduate School of Pharmaceutical Sciences Kyoto University Kyoto Japan., Ziarek JJ; Department of Pharmacology, Feinberg School of Medicine Northwestern University Chicago Illinois USA., Arancio O; Taub Institute for Research on Alzheimer's Disease and the Aging Brain New York New York USA.; Departments of Medicine and Pathology and Cell Biology Columbia University New York New York USA., Watterson DM; Department of Pharmacology, Feinberg School of Medicine Northwestern University Chicago Illinois USA.
Source: Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2025 Mar 27; Vol. 11 (1), pp. e70073. Date of Electronic Publication: 2025 Mar 27 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101650118 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-8737 (Electronic) Linking ISSN: 23528737 NLM ISO Abbreviation: Alzheimers Dement (N Y) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2352-8737
DOI:10.1002/trc2.70073